BRITECYTE

Britecyte is a biotechnology company focused on the development of regenerative medicine therapies. Our pipeline includes tissue allografts and biologic therapies for a broad variety of indications. Our lead program is a biologic therapy for non-alcoholic steatohepatitis (NASH)... Britecyte - a biotech company focused on the development of regenerative medicine therapies to treat metabolic diseases... Britecyte's approach is different from drugs and cell therapies in development. We are developing a biologic therapy that targets multiple pathways in NASH and disrupted metabolism in adipose tissue, the root cause of NASH.

Also known as: Britecyte, Inc.

Primary location: Frederick United States